Jennifer Heideman Selected Research

temsirolimus

1/2017

A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer Heideman Research Topics

Disease

5	Neoplasms (Cancer) 01/2018 - 12/2008
1	Infections 01/2018
1	Cytopenia 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Neutropenia 01/2017
1	Febrile Neutropenia 01/2017
1	Mucositis 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 12/2008
1	Multiple Myeloma 12/2008

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2017 - 06/2015
1	Docetaxel (Taxotere)FDA Link 01/2018
1	ElectrolytesIBA 01/2018
1	temsirolimus FDA Link 01/2017
1	ARQ 197IBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2015
1	Ether (Diethyl Ether)IBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	CLR1404IBA 01/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2015
1	Hormones (Hormone)IBA 12/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2008
1	Bortezomib (Velcade)FDA Link 12/2008

Therapy/Procedure

1	Polypharmacy 06/2015